IGFBP3 and gastrointestinal stromal tumor: Furthermore, if IGFBP3 is indeed acting through an IGF-dependent mechanism, a difference in the expression levels of IGF or IGF-1R or increased sensitivity to IGF might contribute to the differential IGFBP3-induced effects on cell viability and imatinib response in GIST882 or GIST-T1.